Literature DB >> 25381928

Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease.

J S Mertens1, M M B Seyger, W Kievit, E P A H Hoppenreijs, T L Th A Jansen, P C M van de Kerkhof, T R D Radstake, E M G J de Jong.   

Abstract

BACKGROUND: Localized scleroderma (LoS) is characterized by a phase of disease activity followed by remission. However, disease recurrences occur. Knowledge concerning these recurrences can help prompt treatment, thereby preventing disease damage.
OBJECTIVES: To investigate the frequency and characteristics of disease recurrences in paediatric- and adult-onset LoS, and to identify patient variables that are associated with a higher risk of disease recurrence.
METHODS: Retrospective chart reviews were performed of patients with LoS. Data concerning the frequency and characteristics of the disease recurrences were collected. A multivariate analysis was performed to identify patient variables that were associated with a higher risk of disease recurrence.
RESULTS: In total, 344 patients were included in the analysis, of whom 119 (35%) had paediatric-onset LoS and 225 (65%) had adult-onset LoS. Disease recurrence was present in 27% (n = 32) of the paediatric-onset group and 17% (n = 39) of the adult-onset group (P = 0·037). Multivariate analysis identified a statistically significant association between disease recurrence and the linear LoS of the limbs subtype, independent of age at disease onset.
CONCLUSIONS: Recurrences in LoS occurred in almost one-quarter of the patients and were most frequent in the linear LoS of the limbs subtype, independent of age at disease onset. These disease recurrences can occur even after many years of quiescent disease. Awareness of the high recurrence rates may help treating physicians to recognize reactivation of the disease, leading to a decreased delay in treatment reinitiation.
© 2014 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2015        PMID: 25381928     DOI: 10.1111/bjd.13514

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

Review 1.  Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.

Authors:  Oliver Distler; Antonio Cozzio
Journal:  Semin Immunopathol       Date:  2015-11-17       Impact factor: 9.623

2.  Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma.

Authors:  K L Kurzinski; C K Zigler; K S Torok
Journal:  Br J Dermatol       Date:  2018-12-05       Impact factor: 9.302

3.  Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centre.

Authors:  Amanda M Saracino; Christina George; Svetlana I Nihtyanova; Christopher P Denton
Journal:  J Scleroderma Relat Disord       Date:  2020-06-12

4.  Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013.

Authors:  Anagha Bangalore Kumar; Elizabeth K Blixt; Lisa A Drage; Rokea A El-Azhary; David A Wetter
Journal:  J Am Acad Dermatol       Date:  2019-01-29       Impact factor: 11.527

5.  Changes in Disease Activity and Damage Over Time in Patients With Morphea.

Authors:  Jack C O'Brien; Hugh Nymeyer; Allison Green; Heidi T Jacobe
Journal:  JAMA Dermatol       Date:  2020-05-01       Impact factor: 10.282

6.  Interventions for morphea.

Authors:  Julia V de Albuquerque; Brenda Ng Andriolo; Monica Ra Vasconcellos; Vinicius T Civile; Anne Lyddiatt; Virginia Fm Trevisani
Journal:  Cochrane Database Syst Rev       Date:  2019-07-16

Review 7.  Morphea and Eosinophilic Fasciitis: An Update.

Authors:  Jorre S Mertens; Marieke M B Seyger; Rogier M Thurlings; Timothy R D J Radstake; Elke M G J de Jong
Journal:  Am J Clin Dermatol       Date:  2017-08       Impact factor: 7.403

8.  A novel patient-reported outcome for paediatric localized scleroderma: a qualitative assessment of content validity.

Authors:  C K Zigler; K Ardalan; S Lane; K L Schollaert; K S Torok
Journal:  Br J Dermatol       Date:  2019-10-23       Impact factor: 9.302

9.  Magnetic Resonance Imaging Evaluation in Patients with Linear Morphea Treated with Methotrexate and High-Dose Corticosteroid.

Authors:  Mohammad Shahidi-Dadras; Fahimeh Abdollahimajd; Razieh Jahangard; Ali Javinani; Amir Ashraf-Ganjouei; Parviz Toossi
Journal:  Dermatol Res Pract       Date:  2018-07-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.